Sorrento Therapeutics, Inc.
Disulfide bridging conjugates
Last updated:
Abstract:
Provided are bispecific conjugates having the general formula: ##STR00001## pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the treatment of cancer.
Status:
Grant
Type:
Utility
Filling date:
1 Aug 2018
Issue date:
13 Oct 2020